| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 185.154 | 180.567 | 216.541 | 345.460 | 442.569 | 244.776 | 439.502 | 639.935 | 699.556 | 782.272 |
| Total Income - EUR | 185.217 | 180.567 | 216.999 | 346.902 | 442.764 | 258.845 | 450.959 | 644.924 | 706.221 | 790.032 |
| Total Expenses - EUR | 169.815 | 164.561 | 186.821 | 242.259 | 300.711 | 219.338 | 336.822 | 454.289 | 590.816 | 639.826 |
| Gross Profit/Loss - EUR | 15.402 | 16.006 | 30.177 | 104.643 | 142.053 | 39.508 | 114.136 | 190.635 | 115.405 | 150.206 |
| Net Profit/Loss - EUR | 12.936 | 13.441 | 28.093 | 101.182 | 138.389 | 37.836 | 110.689 | 185.618 | 105.344 | 130.656 |
| Employees | 9 | 11 | 9 | 9 | 9 | 9 | 11 | 12 | 14 | 18 |
Check the financial reports for the company - Ovcicodan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.753 | 0 | 15.679 | 12.239 | 7.460 | 3.163 | 218 | 2.150 | 85.441 | 314.048 |
| Current Assets | 146.138 | 129.599 | 174.909 | 229.497 | 205.675 | 236.028 | 183.292 | 412.473 | 456.613 | 381.784 |
| Inventories | 122.802 | 97.226 | 115.594 | 122.320 | 122.197 | 90.466 | 129.717 | 212.884 | 248.671 | 291.530 |
| Receivables | 0 | 1.492 | 0 | 836 | 2.762 | 5.243 | 8.016 | 172.515 | 170.580 | 13.347 |
| Cash | 23.336 | 30.880 | 59.316 | 106.341 | 80.715 | 140.320 | 45.560 | 27.074 | 37.363 | 76.908 |
| Shareholders Funds | 11.691 | 25.013 | 52.683 | 152.898 | 188.506 | 222.769 | 154.136 | 223.581 | 269.136 | 227.191 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 138.201 | 104.585 | 137.906 | 88.838 | 24.629 | 16.423 | 29.375 | 191.042 | 272.918 | 468.948 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Ovcicodan Srl